NYSEARCA:SENS - NYSE Arca - US81727U1051 - Common Stock - Currency: USD
0.5269
0 (-0.27%)
The current stock price of SENS is 0.5269 USD. In the past month the price decreased by -28.49%. In the past year, price increased by 28.51%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 27.95 | 232.41B | ||
ISRG | INTUITIVE SURGICAL INC | 72.92 | 199.67B | ||
BSX | BOSTON SCIENTIFIC CORP | 37.81 | 151.04B | ||
SYK | STRYKER CORP | 30.64 | 146.71B | ||
MDT | MEDTRONIC PLC | 15.9 | 112.15B | ||
BDX | BECTON DICKINSON AND CO | 12.31 | 49.71B | ||
EW | EDWARDS LIFESCIENCES CORP | 29.82 | 45.47B | ||
IDXX | IDEXX LABORATORIES INC | 46.04 | 42.54B | ||
RMD | RESMED INC | 27.78 | 36.98B | ||
DXCM | DEXCOM INC | 52.53 | 33.98B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 15.57 | 32.79B | ||
STE | STERIS PLC | 26.09 | 23.95B |
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. The company is headquartered in Germantown, Maryland and currently employs 117 full-time employees. The company went IPO on 2015-03-04. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
SENSEONICS HOLDINGS INC
20451 Seneca Meadows Pkwy
Germantown MARYLAND 20876 US
CEO: Timothy T. Goodnow
Employees: 117
Phone: 13015157260
The current stock price of SENS is 0.5269 USD. The price decreased by -0.27% in the last trading session.
The exchange symbol of SENSEONICS HOLDINGS INC is SENS and it is listed on the NYSE Arca exchange.
SENS stock is listed on the NYSE Arca exchange.
12 analysts have analysed SENS and the average price target is 1.46 USD. This implies a price increase of 177.47% is expected in the next year compared to the current price of 0.5269. Check the SENSEONICS HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SENSEONICS HOLDINGS INC (SENS) has a market capitalization of 418.27M USD. This makes SENS a Small Cap stock.
SENSEONICS HOLDINGS INC (SENS) currently has 117 employees.
SENSEONICS HOLDINGS INC (SENS) has a support level at 0.52 and a resistance level at 0.54. Check the full technical report for a detailed analysis of SENS support and resistance levels.
The Revenue of SENSEONICS HOLDINGS INC (SENS) is expected to grow by 60.03% in the next year. Check the estimates tab for more information on the SENS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SENS does not pay a dividend.
SENSEONICS HOLDINGS INC (SENS) will report earnings on 2025-08-06, after the market close.
SENSEONICS HOLDINGS INC (SENS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).
The outstanding short interest for SENSEONICS HOLDINGS INC (SENS) is 6.79% of its float. Check the ownership tab for more information on the SENS short interest.
ChartMill assigns a technical rating of 1 / 10 to SENS. When comparing the yearly performance of all stocks, SENS turns out to be only a medium performer in the overall market: it outperformed 60.3% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to SENS. Both the profitability and financial health of SENS have multiple concerns.
Over the last trailing twelve months SENS reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS increased by 21.43% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -84.85% | ||
ROE | -210.24% | ||
Debt/Equity | 0.99 |
ChartMill assigns a Buy % Consensus number of 73% to SENS. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 19.53% and a revenue growth 60.03% for SENS